Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Clover Health Investments, Corp. - Class A Common stock
(NQ:
CLOV
)
1.720
-0.030 (-1.71%)
Official Closing Price
Updated: 4:15 PM EDT, Mar 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Clover Health Investments, Corp. - Class A Common stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
25
26
Next >
Clover Health Desperately Needs Triage, but It Isn’t Doomed Yet
↗
January 14, 2022
Clover Health has a billion dollar yearly book of sales. Selloffs have limits, and we will soon find out if CLOV stock is a dud or a stud.
Via
InvestorPlace
Polestar Looks Like the Right EV Stock At the Wrong Time
↗
January 13, 2022
Polestar has a lot of what I look for in a growth stock. But with valuations likely to correct further, there's no hurry to jump in now.
Via
InvestorPlace
RCL Stock Pressured by Hindenburg Short: 7 Things to Know
↗
January 10, 2022
RCL stock is in the red since 2022 kicked off. Now, Hindenburg Research is taking full advantage of the cruise company's weaknesses.
Via
InvestorPlace
How Did the Meme Stocks Do Last Year? Here’s How
↗
January 08, 2022
Quick, which ones were over 500% up? And which six were more than 45% down?
Via
Talk Markets
CLOV Stock Alert: 4 Things to Know as Clover Health Hits an All-Time Low
↗
January 07, 2022
Shares of Clover Health are declining today due to Humana lowering its membership forecast and Credit Suisse issuing a downgrade.
Via
InvestorPlace
DeskTop Metal Shares Are Still Off Limits to Buyers
↗
January 07, 2022
Off and on the price chart, there's work to be done in DM stock before bullish investors consider taking a long position.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Friday
↗
January 07, 2022
Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...
Via
Benzinga
The Two Faces of Clover Health
↗
January 06, 2022
The Clover Assistant may be great software, but the company behind it is questionable. CLOV Stock is best to be avoided for now.
Via
InvestorPlace
2021: The Year in Charts
↗
January 05, 2022
A look at the charts and themes that tell the story of 2021.
Via
Talk Markets
The Steep Drop In Clover Health Stock Sets up an Entry Opportunity
↗
December 29, 2021
Now that CLOV stock has lost considerable steam. Investors are looking for the company to consolidate and report positive earnings from here.
Via
InvestorPlace
Clover Health Is Not the $2 Billion Stock to Buy for 2022
↗
December 24, 2021
Clover Health's market cap dropped 74% in 2021. As we head into 2022, CLOV stock is not the $2 billion market cap you want to buy.
Via
InvestorPlace
7 of The Best SPAC Stocks to Put on Your 2022 Watchlist
↗
December 23, 2021
SPAC stocks may still be out of favor, but you'll still want to keep an eye on these seven picks with merger deals pending.
Via
InvestorPlace
3 Sleeper Stocks to Buy Now Before 2022 Rolls In
↗
December 23, 2021
2021 is almost over and it produced many ideas for stocks to buy on weakness. Here are three that may recapture investor attention next year.
Via
InvestorPlace
7 Meme Stocks to Sell Before They Lose Momentum
↗
December 17, 2021
Meme stocks run the gamut from senseless to sensible. These seven unfortunately fall in the former camp, so steer clear.
Via
InvestorPlace
Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022
↗
December 16, 2021
Retail investors continue to price meme stocks higher. So it's time to look at 10 meme stocks and consider how they'll fare in 2022.
Via
InvestorPlace
Clover Health: 3 Key Factors That Are Worrisome and 1 That Brings Hope
↗
December 15, 2021
CLOV stock has underperformed in 2021, became a meme stock, and now has many risks and challenges to face to reach profitability.
Via
InvestorPlace
This Buzzed-About Meme Stock Is a No-Brainer Buy at $10
↗
December 13, 2021
Chamath Palihapitiya visited Greenville, South Carolina recently, which triggered rumors that one of his SPACs was buying a gaming giant.
Via
InvestorPlace
This ETF Brings Exposure To Meme Stocks: A Look At The Holdings
↗
December 10, 2021
A new exchange traded fund offers investors the chance to own a basket of companies that are considered “meme stocks.” Here’s the details and holdings on the new...
Via
Benzinga
7 Tempting Stocks to Avoid Until These Key Issues Get Ironed Out
↗
December 09, 2021
Someday, the challenges and hurdles affecting them could clear up. But for now, consider this group of seven popular plays stocks to avoid.
Via
InvestorPlace
Topics
Economy
As Clover Health Stock Gets Diluted, Stockholders Are Giving Up
↗
December 09, 2021
CLOV stock continues to punish long-suffering shareholders as it losses value. The latest public offering is another nail in the coffin.
Via
InvestorPlace
Clover Health Is Now a Penny Stock, Denoting Its Serious Decline
↗
December 08, 2021
CLOV stock is saddled with issues that include a declining share price and operational issues that are only getting more troublesome.
Via
InvestorPlace
MEME ETF: The Top 10 Holdings of the New Roundhill Fund for Meme Stock Investors
↗
December 08, 2021
The new Roundhill MEME ETF (MEME) is live and with it comes an opportunity to invest in a wide variety of meme stocks it holds.
Via
InvestorPlace
Clover Health Appeals to Its Base, But Profits Are in the Distant Future
↗
December 07, 2021
Clover Health has done a great job appealing to the biggest CLOV stock fans on Reddit, but great publicity doesn't make it profitable.
Via
InvestorPlace
Topics
Artificial Intelligence
Don’t Count on a Short Squeeze to Save Vinco Ventures Stock
↗
December 07, 2021
Vinco Ventures was a popular meme stock a few weeks ago due to its short squeeze potential. But now BBIG stock crashed and burned.
Via
InvestorPlace
2 Big Stock Bets That Are Insiders Are Buying Now
↗
December 06, 2021
Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy.
Via
InvestorPlace
With Hope and Hype Gone, Clover Health Will Now Remain a Penny Stock
↗
December 06, 2021
As it struggles to control costs, don't expect continued top-line growth to fuel a recovery for CLOV stock.
Via
InvestorPlace
Why Clover Health Tanked 33.9% in November
↗
December 03, 2021
The company reported earnings and announced a common stock offering last month.
Via
The Motley Fool
If November Is Any Indication, Clover Health Is on Life Support
↗
December 02, 2021
November was brutal for shareholders of Clover Health. CLOV stock lost close to 40% of its value. Trading under $5, it’s tough to recommend.
Via
InvestorPlace
The Engine Boosting Clover Health Stock is a CTO Working to Disrupt Medicare
↗
December 02, 2021
The Clover Assistant is meant to align incentives between health care providers and managed care companies, which could cut costs and create profits. That's what CLOV stock investors should focus on.
Via
InvestorPlace
The Clover Health Dilemma: Is it a Good Buy or Goodbye?
↗
December 01, 2021
Last rites for Clover Health Investments seem premature, but CLOV stock is being challenged off and on the price chart.
Via
InvestorPlace
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
25
26
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.